STAGE IV UTERINE CORPUS CANCER AJCC V7
Clinical trials for STAGE IV UTERINE CORPUS CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UTERINE CORPUS CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV UTERINE CORPUS CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests two drug combinations (olaparib plus either vistusertib or capivasertib) in people with recurrent endometrial, triple-negative breast, ovarian, or related cancers. The goal is to find the safest dose and see if the drugs can control tumor growth. About 159 partic…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Heated chemo during surgery may fight recurrent ovarian cancer
Disease control OngoingThis early-phase trial tests the safety and effectiveness of giving heated chemotherapy directly into the abdomen during surgery for advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants receive this treatment, with some also getting …
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Virus therapy targets Hard-to-Treat endometrial cancer
Disease control OngoingThis early-stage trial tests a specially modified virus (VSV-hIFNbeta-NIS) given through an IV to people with advanced or recurrent endometrial cancer. The virus is designed to attack cancer cells while leaving healthy cells alone, and it includes a tracer to see where it goes in…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC